Chantal management ouster sought by shareholder group; Mosbacher asked to take helm.
This article was originally published in The Rose Sheet
Executive Summary
CHANTAL TERMINATING STANSON MARKETING DISTRIBUTION DEAL under an agreement in principle reached by the two companies, Chantal Pharmaceuticals said. Under the agreement, Stanson will receive 1.2 mil. shares of Chantal common stock and retain a limited right to sell off a portion of its inventory of Chantal's Ethocyn skin care products, returning the balance to Los Angeles-based Chantal.